283 related articles for article (PubMed ID: 29663523)
1. Malignant lymphoma in the HIV-positive patient.
Meister A; Hentrich M; Wyen C; Hübel K
Eur J Haematol; 2018 Jul; 101(1):119-126. PubMed ID: 29663523
[TBL] [Abstract][Full Text] [Related]
2. [Human immunodeficiency virus and lymphoma].
Tazi I; Lahlimi FZ
Bull Cancer; 2021 Oct; 108(10):953-962. PubMed ID: 34246454
[TBL] [Abstract][Full Text] [Related]
3. Favorable outcome of HIV-associated Burkitt lymphoma in the modern combined antiretroviral therapy era.
Vasseur L; Prevot S; Mounier N; Costagliola D; Besson C
Eur J Cancer; 2020 Oct; 138():189-192. PubMed ID: 32896718
[No Abstract] [Full Text] [Related]
4. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
5. The Changing Landscape of Lymphoma Associated with HIV Infection.
Hübel K
Curr Oncol Rep; 2020 Aug; 22(11):111. PubMed ID: 32803474
[TBL] [Abstract][Full Text] [Related]
6. Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.
Spina M; Simonelli C; Talamini R; Tirelli U
J Clin Oncol; 2005 Nov; 23(31):8132-3; author reply 8133-4. PubMed ID: 16258119
[No Abstract] [Full Text] [Related]
7. Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment.
Colebunders R; Dohmen S; Van de Velde A; Pelgrom J; Hermans P
Acta Clin Belg; 2001; 56(5):321-2. PubMed ID: 11770227
[No Abstract] [Full Text] [Related]
8. [Expression of Epstein-Barr virus genome in lymphomas of HIV-infected patients].
Arévalo Velasco A; Cordero M; Carlo VJ; Fuertes Martín A
Med Clin (Barc); 2000 Jun; 115(1):38-9. PubMed ID: 10953840
[No Abstract] [Full Text] [Related]
9. Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection.
Hartmann P; Rehwald U; Salzberger B; Franzen C; Diehl V
Expert Rev Anticancer Ther; 2004 Jun; 4(3):401-10. PubMed ID: 15161439
[TBL] [Abstract][Full Text] [Related]
10. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States.
Howlader N; Shiels MS; Mariotto AB; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1289-96. PubMed ID: 27418269
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated lymphoma.
Kaplan LD
Best Pract Res Clin Haematol; 2012 Mar; 25(1):101-17. PubMed ID: 22409827
[TBL] [Abstract][Full Text] [Related]
12. Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma.
Stebbing J; Mandalia S; Palmieri C; Nelson M; Gazzard B; Bower M
J Clin Oncol; 2005 Nov; 23(33):8538-40; author reply 8540-1. PubMed ID: 16293885
[No Abstract] [Full Text] [Related]
13. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy.
Castelli R; Schiavon R; Preti C; Ferraris L
Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):175-180. PubMed ID: 32294049
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with non-Hodgkin's lymphoma.
Carbone PP
Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
[No Abstract] [Full Text] [Related]
15. Treatment of Burkitt's lymphoma in HIV-positive patients.
Straus DJ
Biomed Pharmacother; 1996; 50(9):447-50. PubMed ID: 8991116
[TBL] [Abstract][Full Text] [Related]
16. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
[TBL] [Abstract][Full Text] [Related]
17. Disseminated plasmablastic lymphoma.
Sharma R; Abdou S; Plymyer MR; Rohatgi C
J Am Coll Surg; 2004 Oct; 199(4):654-5. PubMed ID: 15454154
[No Abstract] [Full Text] [Related]
18. Current status of the treatment of HIV-associated lymphoma.
Kaplan LD
Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156
[No Abstract] [Full Text] [Related]
19. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
20. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K
AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
